awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33488700-E1A217C1-366D-47A0-9AAA-724CA311FD3C
Q33488700-E1A217C1-366D-47A0-9AAA-724CA311FD3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33488700-E1A217C1-366D-47A0-9AAA-724CA311FD3C
Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.
P2860
Q33488700-E1A217C1-366D-47A0-9AAA-724CA311FD3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33488700-E1A217C1-366D-47A0-9AAA-724CA311FD3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53d3c751e73b70f05d8d714a5d7ae3da33ebfbad
P2860
Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy.